This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: National Institute of Health and Medical Research. Active years: 1998-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2009
Title: The Innovations of Alain Fischer
Introduction
Alain Fischer is a prominent inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in genetics and immunology. With a total of 2 patents, Fischer's work has the potential to impact therapeutic approaches in various medical conditions.
Latest Patents
Fischer's latest patents include groundbreaking inventions. The first patent pertains to a gene involved in V(D)J recombination and/or DNA repair. This invention relates to a new gene and protein that play crucial roles in these biological processes. Additionally, it encompasses methods of diagnosis and therapy utilizing this gene and protein, as well as the development of transgenic animals that over- or under-express said gene. The second patent focuses on a method for preventing and treating graft failure in human patients. This invention involves injecting a specific anti-LFA-1 monoclonal antibody to enhance patient outcomes.
Career Highlights
Alain Fischer is affiliated with the Institut National de la Santé et de la Recherche Médicale, where he conducts his research. His work has garnered attention for its innovative approaches to complex medical challenges. Fischer's contributions have positioned him as a leading figure in his field.
Collaborations
Fischer has collaborated with notable colleagues, including Claude Mawas and Daniel Olive. These partnerships have further enriched his research endeavors and expanded the impact of his inventions.
Conclusion
Alain Fischer's innovative work in genetics and immunology exemplifies the potential of scientific research to transform medical practices. His patents reflect a commitment to advancing healthcare solutions and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
